AB0 and rhesus blood groups as a risk factor for ARVI COVID-19

Klin Lab Diagn. 2021 Nov 29;66(11):661-665. doi: 10.51620/0869-2084-2021-66-11-661-665.

Abstract

The frequency of AB0 and Rhesus blood groups was studied in 12120 patients with COVID-19, 5180 convalescent plasma donors and 118801 healthy donors from Moscow, Smolensk, Yakutsk, Minsk and Gomel. In infected individuals, the frequency of blood group A was significantly higher than in uninfected individuals (41,54 % and 34,39 % respectively, p<0,05), and the frequency of blood group 0, on the contrary, was significantly lower (27,69 % and 36,71 %, p<0,05). The frequency of blood group A was particularly high among patients who died from ARVI COVID-19 - 45,51 % vs. 34,39 %, p=0,008. In some groups of patients, there was a decrease in the frequency of Rh-negative individuals (2,23 % vs. 8,30 %, p<0,001).

Keywords: AB0 blood groups; ARVI COVID-19; Rh factor.

MeSH terms

  • ABO Blood-Group System
  • COVID-19 Serotherapy
  • COVID-19* / therapy
  • Humans
  • Immunization, Passive
  • Risk Factors
  • SARS-CoV-2

Substances

  • ABO Blood-Group System